Routine Laboratory Tests
Reste Laboratories currently offers a comprehensive suite of diagnostic tests in the following disciplines:
- Biochemistry
- Immunology
- Haematology
- Endocrinology
- Serology
- Microbiology
- Molecular Biology
Find out more about our test menu here.
Unique Test Offerings
Being a member of Reste Group, Reste Laboratories has first access to unique test offerings which are developed and manufactured by its affiliate, Restalyst.
Current unique test offerings include:
- NPC-REAAD™
About NPC-READD™
NPC-REAAD™ is an in-vitro diagnostic intended for qualitative and semi-qualitative detection of IgA antibodies in human serum samples for nasopharyngeal carcinoma. Detection of EA is associated with higher specificity in comparison to other EBV related markers, resulting in fewer false positive during screening. This is particularly important and is a feature that our customers especially value with NPC-REAAD™. Fewer false positive results reduce unnecessary worry to patients and the requirement for them to undergo unnecessary procedures or treatments.
- GC-REAAD™
About GC-REAAD™
GC-REAAD™ is an in-vitro diagnostic intended for early detection of gastric carcinoma using a patented biomarker. This biomarker was discovered to be expressed at high levels in the patient’s plasma samples. Additionally, risk factor for gastric cancer like Helicobacter pylori (H. pylori) infection, does not influence the biomarkers expression levels within plasma.
- HCC-REAAD™ (Coming Soon)
About HCC-REAAD™
HCC-REAAD™ is an in-vitro diagnostic intended for early detection of hepatocellular carcinoma using a patented biomarker. Elevated levels of this biomarker were identified within hepatocellular carcinoma patients’ plasma. Internal research studies by Restalyst indicated that this patented biomarker produces better sensitivity than AFP.
